HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Kauppinen Selected Research
R Kauppinen Research Topics
Disease
2
Metabolic Diseases (Metabolic Disease)
02/2009 - 11/2000
2
Acute Intermittent Porphyria (Porphyria, Acute)
02/2009 - 08/2000
2
Lymphedema (Milroy Disease)
10/2001 - 02/2001
2
Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency)
05/2001 - 11/2000
1
Neurologic Manifestations (Neurological Manifestations)
02/2009
1
Infections
04/2001
1
Reperfusion Injury
11/2000
1
Infarction (Infarctions)
11/2000
1
Erythropoietic Protoporphyria
09/2000
1
Asthma (Bronchial Asthma)
01/2000
Drug/Important Bio-Agent (IBA)
4
Heme (Haem)
IBA
02/2009 - 08/2000
2
Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)
IBA
02/2009 - 08/2000
2
Vascular Endothelial Growth Factor C
IBA
10/2001 - 02/2001
2
Protoporphyrinogen Oxidase (Protox)
IBA
05/2001 - 11/2000
1
Porphyrins
IBA
02/2009
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
10/2001
1
Neuropilins
IBA
10/2001
1
Vascular Endothelial Growth Factor D
IBA
02/2001
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2001
1
Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
IBA
02/2001
1
Saline Solution
IBA
11/2000
1
lazabemide
IBA
11/2000
1
Monoamine Oxidase (MAO)
IBA
11/2000
1
Selegiline (E250)
FDA Link
Generic
11/2000
1
Ferrochelatase (Heme Synthetase)
IBA
09/2000
1
Sympathomimetics (Sympathomimetic Amines)
IBA
01/2000
Therapy/Procedure
1
Intravesical Administration
04/2001